Gadopentetate Dimeglumine Injection/API

Since Gadopentetate Dimeglumine Injectionwas launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist, and quickly occupied the market with its excellent quality and reasonable price. Up to now, linear gadolinium has been safely used for nearly 30 years, with excellent enhancement effects and few side effects.

Product name: Gadopentetate Dimeglumine Injection

Generic name: Gadopentetate Dimeglumine Injection

Type: Injectable Contrast Media for MRI, Linear Contrast Media

Ingredients: Gadopentetate Dimeglumine

Specification: 10ml:4.69 g; 12ml:5.63 g; 15ml:7.04 g; 20ml:9.38 g

Posology and method of administration: Intravenous injection

Adverse reactions: See the details from the package insert

Shelf life: 36 months

Indication of Gadopentetate Dimegumine Injection

Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.

Precautions of Gadopentetate Dimegumine Injection

Current evidence shows that after repeated use of GBCAs, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic.

The clinical significance of brain gadolinium deposition is unclear.

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

Beiluisa professional contrast media manufacturing companies, we provide gadopentetate dimeglumine, mri contrast medium, contrast media productsand etc. Want to know more? Please contact us.

Другие товары поставщика

	Anti-Diabetic Drugs	The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th...
	Iopamidol Injection	Iopamidol Injectionis the second-generation non-ionic iodinated Contrast Media launched in the global market. In 2015, Beilufirstly launched and li...
	Contrast Media	Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...
	Diethylenetriaminepentaacetic acid (DTPA)	Diethylenetriaminepentaaceticacid (DTPA) CAS No.: 67-43-6 Molecular formula: C₁₄H₂₃N₃O₁₀ Molecular weight: 393.35 Quality standard: CP ...
	Gadobutrol Injection/API	In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contr...

Все товары поставщика

Похожие товары

	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Precautions for the use of Chlortetracycline Premix in livestock feed 1. Strict compliance: &midd...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Chlortetracycline Premix in livestock and poultry feed: 1. Purpose: · Promote the growth o...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Uses of Chlortetracycline Premix ·Livestock and poultry health: Chlortetracycline Premix i...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Characteristics of Chlortetracycline Premix ·Natural fermentation products: Chlortetracycl...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Chlortetracycline Premix is a feed additive that combines chlortetracycline with premix technolog...